REGENERON PHARMACEUTICALS, INC. Stock Issued During Period, Value, Employee Benefit Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- REGENERON PHARMACEUTICALS, INC. stock issued during period, value, employee benefit plan for the quarter ending 2019-06-30 was $11.70M.
- REGENERON PHARMACEUTICALS, INC. stock issued during period, value, employee benefit plan for the quarter ending 2019-03-31 was $10.50M.
- REGENERON PHARMACEUTICALS, INC. stock issued during period, value, employee benefit plan for the quarter ending 2018-03-31 was -$700.00K.
- REGENERON PHARMACEUTICALS, INC. stock issued during period, value, employee benefit plan for the quarter ending 2014-12-31 was $13.13M, a 129.54% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. stock issued during period, value, employee benefit plan for fiscal 2018 was $26.90M, a 38.66% increase from fiscal 2017.
- REGENERON PHARMACEUTICALS, INC. stock issued during period, value, employee benefit plan for fiscal 2017 was $19.40M, a 16.87% increase from fiscal 2016.
- REGENERON PHARMACEUTICALS, INC. stock issued during period, value, employee benefit plan for fiscal 2016 was $16.60M, a 7.92% increase from fiscal 2015.
- REGENERON PHARMACEUTICALS, INC. stock issued during period, value, employee benefit plan for fiscal 2015 was $15.38M, a 17.20% increase from fiscal 2014.
| Period end | Stock Issued During Period, Value, Employee Benefit Plan 3 month | Stock Issued During Period, Value, Employee Benefit Plan 12 month |
|---|---|---|
| 2019-06-30 | $11.70M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $10.50M 10-Q · filed 2019-08-06 | |
| 2018-12-31 | $26.90M 10-K · filed 2019-02-07 | |
| 2018-03-31 | -$700.00K 10-Q · filed 2019-08-06 | |
| 2017-12-31 | $19.40M 10-K · filed 2019-02-07 | |
| 2016-12-31 | $16.60M 10-K · filed 2019-02-07 | |
| 2015-12-31 | $15.38M 10-K · filed 2018-02-08 | |
| 2014-12-31 | $13.13M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09 | $13.13M 10-K · filed 2017-02-09 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $5.72M derived: sum of 4 quarters · filed 2016-02-11 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $5.72M derived: sum of 4 quarters · filed 2016-02-11 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-08 | $5.72M derived: sum of 4 quarters · filed 2016-02-11 |
| 2013-12-31 | $5.72M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $5.72M 10-K · filed 2016-02-11 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-08 | |
| 2012-12-31 | $6.33M 10-K · filed 2015-02-12 | |
| 2011-12-31 | $3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | $6.98M 10-K · filed 2014-02-13 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | |
| 2011-03-31 | $3.40M 10-Q · filed 2012-04-26 | |
| 2010-12-31 | $2.87M 10-K · filed 2013-02-15 | |
| 2009-12-31 | $1.39M 10-K · filed 2012-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |